Bill
S 4380
Bill S 4380 limits off-label antipsychotic use in elderly dementia patients, requiring informed consent and monitoring to protect their health and ensure safe prescribing.
Bill Number: S 4380
Title: Limits the Off-Label Use of Antipsychotic Drugs on Elderly Patients with Dementia
Status: Referred to Health
Introduced: February 04, 2025
Classification: Bill
Bill S 4380 aims to regulate the off-label use of antipsychotic medications in elderly patients diagnosed with dementia. The primary intent of the bill is to protect vulnerable populations from potential harm associated with the inappropriate prescription of these drugs, which can lead to serious side effects and adverse health outcomes.
Restrictions on Off-Label Use: The bill proposes to limit the circumstances under which antipsychotic drugs can be prescribed off-label to elderly patients with dementia. This includes establishing stricter guidelines and criteria that healthcare providers must follow.
Informed Consent Requirements: Healthcare providers will be required to obtain informed consent from patients or their legal guardians before prescribing antipsychotic medications for off-label uses. This provision ensures that patients and their families are fully aware of the risks and benefits involved.
Monitoring and Reporting: The bill mandates regular monitoring and reporting of antipsychotic prescriptions for dementia patients. This includes tracking the reasons for off-label use and any reported adverse effects, which will help in assessing the safety and efficacy of such prescriptions.
Educational Initiatives: The legislation calls for the development of educational programs for healthcare providers regarding the risks associated with off-label prescribing of antipsychotics in elderly patients.
Elderly Patients with Dementia: The primary beneficiaries of this bill are elderly individuals diagnosed with dementia, who may be at risk of receiving inappropriate antipsychotic prescriptions.
Healthcare Providers: Physicians, psychiatrists, and other healthcare professionals will be impacted by the new guidelines and requirements for prescribing antipsychotic medications.
Families and Caregivers: Families and caregivers of dementia patients will have a greater role in the decision-making process regarding medication, ensuring they are informed about treatment options.
Current Status: As of February 4, 2025, the bill has been referred to the Health Committee for further consideration.
Related Legislation: This bill is related to prior-session bills S 6462 and S 5704, as well as companion bill A 4296, which may address similar issues regarding the use of antipsychotic medications in vulnerable populations.
Bill S 4380 represents a significant step towards ensuring the safe and appropriate use of antipsychotic medications among elderly patients with dementia. By imposing restrictions on off-label prescribing and enhancing informed consent and monitoring practices, the legislation seeks to safeguard the health and well-being of a particularly vulnerable demographic.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
